86 related articles for article (PubMed ID: 8405116)
1. (+)-HA 966, a partial agonist at the glycine site coupled to NMDA receptors, blocks formalin-induced pain in mice.
Millan MJ; Seguin L
Eur J Pharmacol; 1993 Jul; 238(2-3):445-7. PubMed ID: 8405116
[TBL] [Abstract][Full Text] [Related]
2. Chemically-diverse ligands at the glycine B site coupled to N-methyl-D-aspartate (NMDA) receptors selectively block the late phase of formalin-induced pain in mice.
Millan MJ; Seguin L
Neurosci Lett; 1994 Aug; 178(1):139-43. PubMed ID: 7816323
[TBL] [Abstract][Full Text] [Related]
3. Discriminative stimulus effects of R-(+)-3-amino-1-hydroxypyrrolid-2-one, [(+)-HA-966], a partial agonist of the strychnine-insensitive modulatory site of the N-methyl-D-aspartate receptor.
Witkin JM; Brave S; French D; Geter-Douglass B
J Pharmacol Exp Ther; 1995 Dec; 275(3):1267-73. PubMed ID: 8531091
[TBL] [Abstract][Full Text] [Related]
4. Agonist-like character of the (R)-enantiomer of 1-hydroxy-3-amino-pyrrolid-2-one (HA-966).
Pullan LM; Verticelli AM; Paschetto KA
Eur J Pharmacol; 1991 Sep; 208(1):25-9. PubMed ID: 1834473
[TBL] [Abstract][Full Text] [Related]
5. Effects of a partial agonist and a full antagonist acting at the glycine site of the NMDA receptor on inflammation-induced mechanical hyperalgesia in rats.
Laird JM; Mason GS; Webb J; Hill RG; Hargreaves RJ
Br J Pharmacol; 1996 Apr; 117(7):1487-92. PubMed ID: 8730744
[TBL] [Abstract][Full Text] [Related]
6. Anticonvulsant effects of the glycine/NMDA receptor ligands D-cycloserine and D-serine but not R-(+)-HA-966 in amygdala-kindled rats.
Löscher W; Wlaź P; Rundfeldt C; Baran H; Hönack D
Br J Pharmacol; 1994 May; 112(1):97-106. PubMed ID: 8032669
[TBL] [Abstract][Full Text] [Related]
7. L-687,414, a low efficacy NMDA receptor glycine site partial agonist in vitro, does not prevent hippocampal LTP in vivo at plasma levels known to be neuroprotective.
Priestley T; Marshall GR; Hill RG; Kemp JA
Br J Pharmacol; 1998 Aug; 124(8):1767-73. PubMed ID: 9756395
[TBL] [Abstract][Full Text] [Related]
8. The glycine/NMDA receptor ligand (+)-HA-966 but not D-cycloserine has potent antidystonic efficacy in a genetic animal model of dystonia.
Löscher W; Richter A
Eur J Pharmacol; 1993 Aug; 239(1-3):245-7. PubMed ID: 8223902
[TBL] [Abstract][Full Text] [Related]
9. Effects of (+)-HA-966 and 7-chlorokynurenic acid on the kinetics of N-methyl-D-aspartate receptor agonist responses in rat cultured cortical neurons.
Kemp JA; Priestley T
Mol Pharmacol; 1991 May; 39(5):666-70. PubMed ID: 1674587
[TBL] [Abstract][Full Text] [Related]
10. R-(+)-HA-966, a glycine/NMDA receptor antagonist, selectively blocks the activation of the mesolimbic dopamine system by amphetamine.
Hutson PH; Bristow LJ; Thorn L; Tricklebank MD
Br J Pharmacol; 1991 Aug; 103(4):2037-44. PubMed ID: 1655150
[TBL] [Abstract][Full Text] [Related]
11. The effect of NMDA receptor glycine site antagonists on hypoxia-induced neurodegeneration of rat cortical cell cultures.
Priestley T; Horne AL; McKernan RM; Kemp JA
Brain Res; 1990 Oct; 531(1-2):183-8. PubMed ID: 2149665
[TBL] [Abstract][Full Text] [Related]
12. The anticonvulsant and behavioural profile of L-687,414, a partial agonist acting at the glycine modulatory site on the N-methyl-D-aspartate (NMDA) receptor complex.
Tricklebank MD; Bristow LJ; Hutson PH; Leeson PD; Rowley M; Saywell K; Singh L; Tattersall FD; Thorn L; Williams BJ
Br J Pharmacol; 1994 Nov; 113(3):729-36. PubMed ID: 7858861
[TBL] [Abstract][Full Text] [Related]
13. Effects of N-methyl-D-aspartate receptor antagonists on acute morphine-induced and l-methadone-induced antinociception in mice.
Fischer BD; Carrigan KA; Dykstra LA
J Pain; 2005 Jul; 6(7):425-33. PubMed ID: 15993820
[TBL] [Abstract][Full Text] [Related]
14. The antinociceptive effect of combined systemic administration of morphine and the glycine/NMDA receptor antagonist, (+)-HA966 in a rat model of peripheral neuropathy.
Christensen D; Idänpään-Heikkilä JJ; Guilbaud G; Kayser V
Br J Pharmacol; 1998 Dec; 125(8):1641-50. PubMed ID: 9886755
[TBL] [Abstract][Full Text] [Related]
15. Anticonvulsant activity of antagonists and partial agonists for the NMDA receptor-associated glycine site in the kindling model of epilepsy.
Rundfeldt C; Wlaź P; Löscher W
Brain Res; 1994 Aug; 653(1-2):125-30. PubMed ID: 7982045
[TBL] [Abstract][Full Text] [Related]
16. N-antipyrine-3, 4-dichloromaleimide, an effective cyclic imide for the treatment of chronic pain: the role of the glutamatergic system.
Quintão NL; da Silva GF; Antonialli CS; de Campos-Buzzi F; Corrêa R; Filho VC
Anesth Analg; 2010 Mar; 110(3):942-50. PubMed ID: 20185671
[TBL] [Abstract][Full Text] [Related]
17. NMDA receptor antagonists, MK-801 and ACEA-1011, prevent the development of tonic pain following subcutaneous formalin.
Vaccarino AL; Marek P; Kest B; Weber E; Keana JF; Liebeskind JC
Brain Res; 1993 Jul; 615(2):331-4. PubMed ID: 8364741
[TBL] [Abstract][Full Text] [Related]
18. Kinetic study of the interactions between the glutamate and glycine recognition sites on the N-methyl-D-aspartic acid receptor complex.
Priestley T; Kemp JA
Mol Pharmacol; 1994 Dec; 46(6):1191-6. PubMed ID: 7808441
[TBL] [Abstract][Full Text] [Related]
19. N-methyl-D-aspartate receptor-mediated modulations of the anti-allodynic effects of 5-HT1B/1D receptor stimulation in a rat model of trigeminal neuropathic pain.
Kayser V; Latrémolière A; Hamon M; Bourgoin S
Eur J Pain; 2011 May; 15(5):451-8. PubMed ID: 20965753
[TBL] [Abstract][Full Text] [Related]
20. The glycine B receptor partial agonist, (+)-HA966, enhances induction of antinociception by RP 67580 and CP-99,994.
Seguin L; Millan MJ
Eur J Pharmacol; 1994 Feb; 253(1-2):R1-3. PubMed ID: 8013534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
